Second Survey of Intensive Care in India

Completed

• Conditions: Critical Illness

• Registration Number: NCT03631927
• Lead Sponsor: Indian Society of Critical Care Medicine

Brief Summary

INDICAPS was the first large scale, multicentre survey launched by the ISCCM. The aim was to gather information about ICUs, organizational characteristics, patient casemix, the types and severity of illness, monitoring and therapeutic modalities used, types of infections, and other such data. This was performed between July 2010 and April 2011 and published in 2016.\[1\] Over the last 8 years, there has been a significant difference in the delivery of intensive care services, critical care education, socioeconomic indicators, antibiotic resistance patterns and other aspects of practices in Indian ICUs. It is therefore necessary to revisit and resurvey the current trends in intensive care practices in India, and to reflect the vast spectrum of critical care illness, services and practices.

Similar to INDICAPS, which was a point-prevalence study of all patients present in the ICU on four different days over a one-year period, INDICAPS II will record data of all patients admitted to the ICU on 4 different days.

Detailed Description

INDICAPS II will record data of all patients admitted to the ICU on 4 different days (August 23, 2018; October 25, 2018; December 13, 2018; April 11, 2019) in a cross-sectional design. Data collection includes:

1. On admission: demographic characteristics, comorbidities, source of admission, primary and secondary admission diagnoses,

2. Baseline data (on the study day), including parameters used to calculate SAPS II score and SOFA score and infections,

3. Information on monitoring modalities, mechanical ventilation, nutrition, fluid therapy, other routine ICU practices

c. Outcome at ICU and hospital discharge d. Organisation of ICU services

Study Timeline

• Study First Submitted: 2018-08-13
• Study First Submitted QC: 2018-08-13
• Study First Posted: 2018-08-15
• Study Start: 2018-08-23
• Primary Completion: 2019-04-11
• Study Completion: 2019-05-11
• Results First Submitted: 2021-10-12
• Status Verified: 2021-11
• Results First Submitted QC: 2021-11-10
• Last Update Submitted: 2021-11-10
• Results First Posted: 2021-11-11
• Last Update Posted: 2021-11-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5094

Inclusion Criteria

• All patients present in the ICU on August 23, 2018; October 25, 2018; December 13, 2018; April 11, 2019

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ICU Mortality	30 days from the study day	Number of patients who died in the ICU, as well as those terminally discharged from the ICU

Secondary Outcome Measures

Name	Time	Method
Hospital Mortality	30 days from the study day	all cause hospital mortality, including those terminally discharged from the ICU
ICU Length of Stay	upto 30 days from the study day	length of stay in the intensive care unit
Hospital Length of Stay	upto 30 days from the study day	length of stay in the hospital

Trial Locations

Locations (104)

Nri Medical College & General Hospital; 🇮🇳 Guntur, Andhra Pradesh, India

CARE Hospitals; 🇮🇳 Visakhapatnam, Andhra Pradesh, India

Sevenhills Hospital; 🇮🇳 Visakhapatnam, Andhra Pradesh, India

Nemcare Hospital; 🇮🇳 Guwahati, Assam, India

Apollo hospitals; 🇮🇳 Guwahati, Assam, India

Ayursundra superspecialty Hospital; 🇮🇳 Guwahati, Assam, India

Paras Hmri Hospital; 🇮🇳 Patna, Bihar, India

All India Institute of Medical Sciences,Patna; 🇮🇳 Patna, Bihar, India

Narayana Super Speciality Hospital; 🇮🇳 Gurgaon, Delhi, India

Nayati Medecity; 🇮🇳 Mathura, Delhi, India

Scroll for more (94 remaining)